Gas Relief
NDC Package 68016-643-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Gas Relief is a medication used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. Marketed by Chain Drug Consortium, this product is identified by NDC 68016-643 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
68016-643-30
Package Description
3 BLISTER PACK in 1 CARTON / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
Product Code
11-Digit Billing Format
68016064330

Clinical Specifications

Proprietary Name
Gas Relief Extra Strength
Dosage Form
-
Usage Information
This product is used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. Simethicone helps break up gas bubbles in the gut.

Regulatory & Marketing

Labeler Name
Chain Drug Consortium
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-01-2015
End Marketing Date
02-04-2023
Listing Expiration
02-04-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68016-643-30 identifies a specific commercial package of 3 blister pack in 1 carton / 10 capsule, liquid filled in 1 blister pack of Gas Relief Extra Strength, labeled by Chain Drug Consortium. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium on March 01, 2015. The current certification is valid through February 04, 2023.

What are the primary indications for this medication?

This product is used to relieve symptoms of extra gas caused by air swallowing or certain foods/infant formulas. Simethicone helps break up gas bubbles in the gut.

How is this Chain Drug Consortium product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016064330. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68016-643-30
11-Digit CMS (5-4-2)
68016-0643-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.